Medical Grand Rounds: Advancing New Therapies for COVID-19: Antiviral, Immunomodulation and Beyond
In This Article
- On April 9, 2020, the Department of Medicine at Massachusetts General Hospital held its fifth virtual Grand Rounds presentation related to COVID-19
- Keith Flaherty, MD, at the Mass General Cancer Center, and Scott Gottlieb, MD, former FDA commissioner, along with other members of the Greater Boston medical community, presented on advancing experimental therapies to treat COVID-19
On April 9, 2020, the Department of Medicine at Massachusetts General Hospital held its fifth virtual Grand Rounds presentation related to COVID-19. Keith Flaherty, MD, director of Clinical Research at the Mass General Cancer Center, along with other members of the Greater Boston medical community, presented on advancing experimental therapies through clinical trials to treat COVID-19.
Subscribe to the latest updates from Advances in Motion
The session was moderated by Katrina Armstong, MD, physician-in-chief in the Department of Medicine at Mass General. Speakers included Michael Mansour, MD, PhD, physician and researcher in the Division of Infectious Diseases, and Kathryn Hibbert, MD, physician and researcher in the Division of Pulmonary & Critical Care Medicine at Mass General; Kathryn Stephenson, MD, MPH, and Barbra Blair, MD, from Beth Israel Deaconess Medical Center; Richard Kaufman, MD, from Brigham and Women’s Hospital; and Scott Gottlieb, MD, former commissioner of the Food and Drug Administration and current fellow at the American Enterprise Institute.
Watch the Video »
View all COVID-19 Updates
Learn about COVID-19 Grand Rounds at Mass General